针对静脉腿部的塔瓦博罗尔向阿基纳-1的计算治疗重定位
Naveen Kumar V1, T Tamilanban1
1Department of Pharmacology, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu, Tamil Nadu - 603 203, India.
Computational biology and chemistry
|June 6, 2024
概括
重新使用酸盐药物,如塔瓦博罗尔来抑制阿尔基纳-1,可能提供新的静脉腿 (VLU) 治疗方法. 分子研究表明,塔瓦博罗尔有效地与酶结合.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 计算化学的计算化学
背景情况:
- 静脉腿 (VLU) 是与衰老和生活方式因素相关的日益严重的医疗保健问题.
- 目前的VLU治疗在解决疾病的复杂性方面面临挑战.
- 阿基纳1酶的活性与VLU的病变发生有关.
研究的目的:
- 调查重新利用酸盐药物的潜力,以抑制VLU治疗的阿尔金酶1的可能性.
- 用计算方法评估塔瓦博罗尔与阿基因酶1的结合亲和力和相互作用.
主要方法:
- 使用施罗丁格GLIDE的分子对接模拟,针对阿基因酶1酶 (2PHO).
- 使用Gromacs-2019.4进行分子动态模拟 (500nS),以分析连接体-蛋白质复合体的稳定性.
- 轨迹分析包括RMSD,RMSF,RG,SASA和H-Bond分析. 这些分析包括:
主要成果:
- 与L-氨酸和L-诺瓦氨酸相比,塔瓦博的对接得分 (-3957 kcal/mol) 较高.
- 塔瓦博罗尔证明与阿尔金酶1的催化部位结合,与酸相互作用.
- 分子动力学研究证实了蛋白质连接体复合物的稳定性和紧性.
结论:
- 塔瓦博罗尔作为酶1抑制剂对潜在的VLU治疗应用具有前途.
- 计算建模支持塔瓦博罗尔与阿基因酶1活性位点的稳定相互作用.
- 需要进一步的研究来探索塔瓦博罗尔在VLU治疗中的有效性.
相关概念视频
01:27Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K